The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Acelyrin Inc shares valued at $7 were sold by Becker Daniel J. on Jul 17 ’24. At $6.86 per share, Becker Daniel J. sold 1 shares. The insider’s holdings dropped to 2,999 shares worth approximately $10616.460000000001 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lin Shao-Lee sold 9,961 shares, netting a total of over 66,024 in proceeds. Following the sale of shares at $6.63 each, the insider now holds 1,577,374 shares.
Before that, Lin Shao-Lee had sold 15,701 shares from its account. In a trade valued at $119,403, the Chief Executive Officer traded Acelyrin Inc shares for $7.60 each. Upon closing the transaction, the insider’s holdings decreased to 15,701 shares, worth approximately $5.62 million.
As published in a research note from H.C. Wainwright on August 14, 2024, Acelyrin Inc [SLRN] has been rated down from a Buy to a Neutral and the price target has been revised to $6 from $18. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in early July. As of December 13, 2023, Wells Fargo has initiated its “an Equal weight” rating for SLRN. Earlier on December 08, 2023, Citigroup initiated its rating. Their recommendation was “a Neutral” for SLRN stock.
Analyzing SLRN Stock Performance
During the last five days, there has been a drop of approximately -15.91%. Over the course of the year, Acelyrin Inc shares have dropped approximately -52.55%. Shares of the company reached a 52-week high of $8.89 on 03/01/24 and a 52-week low of $3.18 on 12/11/24. A 50-day SMA is recorded $5.22, while a 200-day SMA reached $5.30. Nevertheless, trading volume fell to 1.47 million shares from 3.27 million shares the previous day.
Support And Resistance Levels for Acelyrin Inc (SLRN)
According to the 24-hour chart, there is a support level at 3.37, which, if violated, would cause prices to drop to 3.20. In the upper region, resistance lies at 3.72. The next price resistance is at 3.90. RSI (Relative Strength Index) is 26.53 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.61, which suggests the price will decrease in the coming days. Percent R is at 80.49%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
